熱門資訊> 正文

首席执行官购买10万股后，KURA股价上涨9%

2026-08-25 18:02

Kura Oncology(KURA) 0
XMax Inc(XMAX) 0

Kura Oncology (KURA) stock price jumped ~8.7% after President and CEO Troy Wilson purchased 100,000 shares of the cancer drug developer.
Wilson bought the shares on August 17 at a weighted average price of $11.12 per share, representing an investment of about $1.1M, according to a Form 4 filing.
The purchases were executed at prices ranging from $10.87 to $11.31 per share.
Following the transaction, Wilson held 435,456 Kura Oncology shares directly, while additional shares were held indirectly through two trusts.

More on Kura Oncology

Kura Oncology, Inc. (KURA) Q2 2026 Earnings Call Transcript
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma - Slideshow
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma Transcript
Kura Oncology rises after hours on large CEO share purchase
Kura outlines $90M-$110M 2027 collaboration revenue while targeting 2028 KOMET-017 topline results

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。